Links
[1] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts-old
[2] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=24
[3] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=27
[4] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=34
[5] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/prevalencia-de-masas-de-gl%C3%A1ndulas-adrenales-identificadas-de-forma
[6] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/las-concentraciones-s%C3%A9ricas-de-25-hidroxivitamina-d-en-perros-con
[7] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=35
[8] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/concordancia-entre-citolog%C3%ADa-e-histolog%C3%ADa-en-el-diagn%C3%B3stico-de
[9] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=26
[10] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/uso-de-un-sistema-de-clasificaci%C3%B3n-histol%C3%B3gica-de-2-pasos-para
[11] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/caracterizaci%C3%B3n-retrospectiva-del-histiocitoma-cut%C3%A1neo-solitario
[12] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/factores-de-pron%C3%B3stico-cl%C3%ADnico-en-el-sarcoma-histioc%C3%ADtico-canino
[13] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=29
[14] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts?field_specialities_tid=32
[15] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/asociaci%C3%B3n-entre-la-condici%C3%B3n-corporal-y-el-pron%C3%B3stico-del-c%C3%A1ncer
[16] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/vinblastina-como-segundo-rescate-en-el-tratamiento-del-linfoma
[17] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/evaluaci%C3%B3n-de-la-seguridad-de-la-combinaci%C3%B3n-doxorrubicina-y
[18] https://www.affinity-petcare.com/veterinary/actualidad-veterinaria/abstracts/respuesta-cl%C3%ADnica-del-masitinib-mesilato-en-el-tratamiento-del
[19] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34
[20] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=9
[21] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=6
[22] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=7
[23] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=8
[24] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=11
[25] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=12
[26] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=13
[27] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=14
[28] https://www.affinity-petcare.com/veterinary/print/6?field_specialities_tid=34&page=26